Tirzépatide

Tirzépatide

Nom du produit Tirzépatide
Numéro CAS 2023788-19-2
Formule moléculaire C225H348N48O68
Poids moléculaire 4813.45 g/mol
Apparence Poudre blanche à blanc cassé
Pureté ≥98% (HPLC)
Solubilité Soluble in water, DMSO, and ethanol
Colis 1g, 5g, 10g, 100g, or custom

Besoin d'aide ? Contacter notre équipe

Tirzepatide Structure

Synonyms: Tirzepatide, 2023788-19-2, GIP/GLP-1 receptor agonist, LY3298176, Mounjaro, Zepbound, Glucagon-like peptide-1 receptor agonist

Tirzepatide has been making headlines in the pharmaceutical world as a first-in-class dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Originally developed by Eli Lilly and approved for type 2 diabetes under the brand name Mounjaro, it has quickly become a cornerstone in metabolic disease management, with expanding applications in obesity and cardiovascular health. Its unique mechanism not only enhances glycemic control but also delivers superior weight loss outcomes, which has positioned it as one of the most anticipated peptide therapeutics of the decade.

 

At LyvBio, we supply high-purity Tirzepatide (≥98% by HPLC) in research and development quantities, meeting strict quality criteria. Our product is available as a lyophilized powder, ideal for reconstitution in laboratory settings. Whether you’re conducting preclinical studies, formulation development, or analytical method validation, our Tirzepatide offers reliable performance and comprehensive documentation.

Product Overview

Our product is supplied as a white to off-white powder, freely soluble in water and common organic solvents. Each batch is characterized by mass spectrometry and HPLC to confirm identity and purity, ensuring that researchers receive a consistent and reliable material for their studies.

Key Applications

  • Type 2 Diabetes Research: Used in studies evaluating glycemic control and beta-cell function.
  • Obesity and Weight Management: Investigated for its potent anorectic effects and ability to reduce body weight.
  • Cardiovascular Studies: Explored for potential benefits in reducing cardiovascular risk factors.
  • Peptide Synthesis Development: Serves as a reference standard for analytical method development and quality control.

Quality & Standards

Paramètre Spécifications
Essai (HPLC) ≥98,01 TP3T
Apparence Poudre blanche à blanc cassé
Perte au séchage ≤5,0%
Métaux lourds ≤ 10 ppm
Purity (related substances) Meets internal requirements

Packaging & Supply

  • Emballage: Sealed vials or bottles, with desiccant if required.
  • Quantité minimale de commande: 5 g
  • Délai de livraison: 5-7 business days after order confirmation.
  • Documentation: COA, MSDS, TDS, and HPLC chromatogram provided with each shipment.

Demande de devis

  • Notre adresse: 280, rue Main, Xi'an, Shaanxi, Chine
  • LyvBio Co. — E-mail : info@lyvbio.com

RESTEZ EN CONTACT

Demande de devis

Notre adresse

Room,5-0203, Courtyard 205, Lianhu District,Xi'an,Shaanxi,China

×